ProfessorCharles Coombes, FMedSci

Emeritus Professor of Medical Oncology

Department of Surgery & Cancer - Faculty of Medicine

PROFESSIONAL ACTIVITIES

  • AWARD
    300,000 Co-PI
    1 Mar 2011
    Merieux Foundation Eu 1 March 2011 - 1 March 2014
  • EXTERNAL COMMITTEE
    CR(UK) Biological Sciences Committee
    1 Jan 2011
  • AWARD
    £270,000 Co-PI
    1 Jan 2011
    BRC 1 Jan 2011 - 1 Jan 2014
  • AWARD
    £1,639.347 PI
    1 Oct 2010
    CRUK 1 Oct 10 -30 Sept 13
  • AWARD
    £775,455 PI
    1 Apr 2010
    CRUK 1 Apr 10 - 31 Mar 13
  • AWARD
    £46,824 Co-PI
    1 Jan 2010
    CRUK 1 Jan 10 - 31 Dec 12
  • EXTERNAL COMMITTEE
    CRUK Senior Scientific Advisory Group
    1 Jan 2009
  • AWARD
    Nominated NIHR senior Investigator 2009; one of 100 in the UK
    1 Jan 2009
    NIHR
  • AWARD
    £71,124.30 PI
    1 Mar 2008
    Pfizer Ltd 1 Mar 08 - 28 Feb 11
  • EXTERNAL COMMITTEE
    Research Assessment Excercise (UK) Cancer Board
    1 Jan 2008
  • AWARD
    £50,000 PI
    1 Jan 2008
    Novartis Pharma 1 Jan 08 - 31 Dec 12
  • AWARD
    £79,974 PI
    1 Jan 2008
    CRUK 1 Jan 08 - 30 Jun 11
  • AWARD
    £348,576 PI
    1 Sep 2007
    CRUK 1 Sep 07 - 28 Feb 11
  • AWARD
    £310,515.23 Co-PI
    1 Jul 2007
    CRUK 1 Jul 07 - 30 Apr 10
  • AWARD
    £143,379 PI
    1 Dec 2006
    CRUK 1 Dec 06 - 30 Apr 11
  • EXTERNAL COMMITTEE
    Biomedical Research Centre Committee
    1 Jan 2006
  • EXTERNAL COMMITTEE
    CS SORA Divisional Committee
    1 Jan 2005
  • EXTERNAL COMMITTEE
    IC Clinical Trials Committee
    1 Jan 2005
  • AWARD
    £1,190.159.98 PI
    1 Jan 2004
    Pfizer Inc 1 Jan 04 - 31 Dec 11
  • AWARD
    £15,289.02 PI
    1 Jan 2004
    Pfizer Inc 1 Jan 04 - 31 Dec 11
  • EXTERNAL COMMITTEE
    Breast International Group
    1 Jan 2001
  • AWARD
    FMedSci
    1 Jan 2001
  • EXTERNAL COMMITTEE
    Trustee of the Breast Cancer Research Trust
    1 Jan 2001
  • EXTERNAL COMMITTEE
    ICR Trials Oversee Group
    1 Jan 2000
  • INDUSTRIAL CONNECTION
    International Cancer Collaborative Group
    1 Jan 1981
    This has entailed detailed collaboration with Industry. Nearly all of the 15 staff are or have been funded by Industry sources.